Insider Transactions in Q1 2025 at Standard Biotools Inc. (LAB)
Insider Transaction List (Q1 2025)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Mar 21
2025
|
Sean Mackay SVP & Chief Business Officer |
BUY
Grant, award, or other acquisition
|
Direct |
281,667
+24.21%
|
-
|
|
Mar 21
2025
|
Hanjoon Alex Kim Chief Financial Officer |
BUY
Grant, award, or other acquisition
|
Direct |
338,333
+27.5%
|
-
|
|
Mar 21
2025
|
Michael Egholm President & CEO |
BUY
Grant, award, or other acquisition
|
Direct |
1,188,333
+31.07%
|
-
|
|
Feb 28
2025
|
Casdin Partners Master Fund, L.P. Director |
BUY
Grant, award, or other acquisition
|
Direct |
58,215
+2.03%
|
$58,215
$1.06 P/Share
|
|
Feb 28
2025
|
Casdin Partners Master Fund, L.P. Director |
SELL
Other acquisition or disposition
|
Indirect |
545,000
-100.0%
|
$545,000
$1.06 P/Share
|
|
Feb 28
2025
|
Casdin Partners Master Fund, L.P. Director |
BUY
Other acquisition or disposition
|
Indirect |
545,000
+0.91%
|
$545,000
$1.06 P/Share
|
|
Feb 28
2025
|
Casdin Partners Master Fund, L.P. Director |
BUY
Open market or private purchase
|
Indirect |
4,820,959
+7.57%
|
$4,820,959
$1.06 P/Share
|
|
Feb 28
2025
|
Troy Cox |
BUY
Grant, award, or other acquisition
|
Direct |
62,910
+21.87%
|
$62,910
$1.06 P/Share
|
|
Feb 28
2025
|
Thomas D. Carey |
BUY
Grant, award, or other acquisition
|
Direct |
56,338
+36.16%
|
$56,338
$1.06 P/Share
|
|
Feb 20
2025
|
Michael Egholm President & CEO |
SELL
Payment of exercise price or tax liability
|
Direct |
31,031
-2.1%
|
$31,031
$1.39 P/Share
|